Optimization of an Experimental Vaccine To Prevent Escherichia

Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity, Microbial Cell Factories

Virus-like Particle (VLP) Vaccine Bioprocessing and Formulation Steps

Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines

STAR-0215 is a Novel, Long-Acting Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Potential Treatment of Hereditary Angioedema

Research implementation and evaluation of the maternity waiting home program for enhancing maternal health in remote area of Indonesia - Clinical Epidemiology and Global Health

Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity, Microbial Cell Factories

Frontiers Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing Escherichia coli

Current view on novel vaccine technologies to combat human infectious diseases

Vaccine-induced COVID-19 mimicry syndrome